JENNIFER CONBOY: Open Payments
NPI 1295251254 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 64 payments from 20 companies in 2025. Trend: 2023 $1,529 · 2024 $343 · 2025 $1,324
Food & beverage: $1,324
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $277 |
| Dexcom, Inc. | 3 | $177 |
| Abbott Laboratories | 7 | $142 |
| Amgen Inc. | 7 | $136 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| Antares Pharma, Inc. | 3 | $60 |
| Madrigal Pharmaceuticals | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Sequel Med Tech, LLC | 2 | $46 |
| BETA BIONICS, INC. | 1 | $43 |
Products named: Dexcom G6 Transmitter, Ozempic, FREESTYLE LIBRE 3, TEPEZZA, XYOSTED, REZDIFFRA, JARDIANCE, RECORLEV.
Industry payments across CT — which companies pay providers there.
